サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1512667

腸内健康プロバイオティクスサプリメントの世界市場：2024年～2031年

Global Gut Health Probiotic Supplements Market - 2024-2031

出版日
ページ情報
英文 235 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
腸内健康プロバイオティクスサプリメントの世界市場：2024年～2031年
出版日: 2024年07月10日
発行: DataM Intelligence
ページ情報: 英文 235 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界の腸内健康プロバイオティクスサプリメント市場は、2023年に48億米ドルに達し、2024-2031年の予測期間中にCAGR 11.1％で成長し、2031年には104億米ドルに達すると予測されています。

健康意識の高まり、人口の高齢化、ライフスタイルの変化が消化器の健康に影響を与え、様々な疾患につながります。世界の腸内健康プロバイオティクスサプリメント市場は、プロバイオティクスに関連する消化器系の健康効果に対する消費者の意識の高まりに牽引され、着実に拡大しています。全体的な健康のためには消化器系を健康に保つことが重要であるという認識が高まる中、消費者の腸の健康への注目が市場の成長を後押ししています。

消費者は、それぞれの特定の健康状態に対処するためにプロバイオティクスを好みます。2022年にCRNは、特殊なサプリメントの使用が増加していると報告しました。サプリメントの半数以上（52％）の消費者が特殊なサプリメントを体内に取り入れており、最も一般的に使用されているのはオメガ3、プロバイオティクス、メラトニン、食物繊維などです。

北米は消化器系ヘルスケア製品の需要が高く、市場を独占しています。NIHによると、米国では約6,000～7,000万人が消化器系疾患を抱えているといいます。Council for Responsible Nutritionが2022年8月に実施した調査によると、18歳以上の米国成人3,133人のうち、2,342人が栄養補助食品を時々、定期的に、または季節的に利用していると回答しました。

市場力学

消費者の健康志向の高まり

消化器系や腸の健康問題が蔓延するにつれ、健康に役立つ製品への需要が高まっています。米国国立衛生研究所（National Institute of Health）によると、インターネット調査を利用した包括的な多国間調査で、世界人口の40％以上が胃腸の問題を経験していることが判明しました。下痢、便秘、過敏性腸症候群（IBS）の有病率は、それぞれ4.7％、11.7％、4.1％と報告されています。

消費者は、健康上の問題を予防し、生活の質を高めたいという願望から、消化器系の健康をサポートする製品をより積極的に求めるようになっています。腸内細菌叢のバランスと消化機能をサポートすることで知られる有益なバクテリアを含むプロバイオティクスサプリメントは、こうした健康目標を達成するための便利で効果的な方法として人気を集めており、市場の成長を牽引しています。

消費者によるプロバイオティクス消費の増加

消費者は、消化器系の健康や免疫機能の改善など、プロバイオティクスに関連する健康上の利点について認識を深めています。予防医療と総合的なウェルネスへの注目が高まり、消費者は腸の健康をサポートする製品を求めるようになっています。プロバイオティクスは、健康的な消化器系を促進する自然で効果的なサプリメントとして認識されています。

国際食品情報協議会（International Food Information Council）が2021年に実施した調査では、米国人の51％が腸の健康を促進するためにプロバイオティクスを食生活に取り入れ、33％が免疫機能を強化するためにプロバイオティクスを使用し、38％が全体的な健康とウェルネスを目的としてプロバイオティクスを取り入れ、13％が感情的な幸福をサポートするためにプロバイオティクスを摂取していると回答しています。プロバイオティクスサプリメントの利用拡大が、市場の成長拡大に並行して進んでいます。

消費者の認識不足

消費者の多くは、心臓発作、脳卒中、認知症のリスクの増加など、腸内環境の悪化が健康に及ぼす影響について知らないです。MDVIPの調査によると、アメリカ人の5人に3人は腸内環境が悪いと心臓発作、脳卒中、認知症のリスクが高まることを知らないです。アメリカ人の3分の2が腸の問題を抱えたまま生活しており、健康への影響に気づいていないです。

このような認識不足は、プロバイオティクスサプリメントを含む腸内健康製品の需要低下につながる可能性があります。プロバイオティクスが消化器の健康、免疫機能、そして健康全般にどのように寄与するのかについて明確な理解がなければ、消費者はこうしたサプリメントを不可欠なもの、あるいは有益なものと認識しないかもしれないです。これは市場成長の可能性を制限します。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 消費者の健康志向の高まり
      • 消費者のプロバイオティクス消費の増加
    • 抑制要因
      • 消費者の認識不足
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • DMIの見解

第6章 COVID-19分析

第7章 菌株別

  • 乳酸菌
  • ビフィズス菌
  • ストレプトコッカス
  • その他

第8章 形状別

  • 錠剤
  • カプセル
  • 液体
  • 粉末
  • その他

第9章 流通チャネル別

  • 薬局/ドラッグストア
  • 専門店
  • オンライン小売
  • その他

第10章 年齢層別

  • 子供
  • 大人
  • シニア

第11章 用途別

  • 一般的な消化器系の健康
  • 特定の健康状態
    • 過敏性腸症候群（IBS）
    • 炎症性腸疾患（IBD）
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • The Good Bug
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Zeroharm Sciences Private Limited
  • Menoveda Life Sciences Private Limited
  • Unique Biotech Limited
  • Projoy Pvt Ltd
  • Nature's Bounty
  • Hyperbiotics
  • Advanced Vital Enzymes Private Ltd
  • Wren Laboratories Ltd
  • Nordic Naturals

第15章 付録

目次
Product Code: FB8514

Overview

Global Gut Health Probiotic Supplements Market reached US$ 4.8 billion in 2023 and is expected to reach US$ 10.4 billion by 2031, growing with a CAGR of 11.1% during the forecast period 2024-2031.

Rising health consciousness, ageing populations, and lifestyle changes impact digestive health and lead to various disorders. The global gut health probiotic supplements market has been expanding steadily, driven by increasing consumer awareness of the digestive health benefits associated with probiotics. With increasing awareness about the importance of maintaining a healthy digestive system for overall well-being, consumer focus on gut health drives market growth.

Consumers prefer probiotics to deal with respective and specific health conditions. In 2022, CRN reported that there had been a rise in the usage of speciality supplements. Over half of the supplement, consumers (52%) incorporate specialty supplements into their system, with the most commonly used types including omega-3s, probiotics, melatonin and fiber.

North America dominates the market with the high demand for digestive health care products. According to NIH, around 60 to 70 million people in the U.S. live with a digestive disease. The Council for Responsible Nutrition surveyed in August 2022 and stated that among 3,133 U.S. adults aged 18 and older, including 2,342 adults they indicated they use dietary supplements occasionally, regularly, or seasonally.

Dynamics

Growing Health Consciousness Among Consumers

With the increasing prevalence of digestive and gut health problems, there is increasing demand for products that provide health benefits. According to the National Institute of Health, in a comprehensive multinational study using internet surveys, it was found that over 40% of the global population experiences gastrointestinal issues. The prevalence rates of diarrhea, constipation, or irritable bowel syndrome (IBS), were reported to be 4.7%, 11.7%, and 4.1%, respectively.

Consumers are becoming more proactive in seeking products that support digestive health, driven by a desire to prevent health issues and enhance their quality of life. Probiotic supplements, which contain beneficial bacteria known to support gut flora balance and digestive function, are gaining popularity as a convenient and effective way to achieve these health goals, driving market growth.

Increasing Consumer Probiotics Consumption

Consumers are becoming more aware of the health benefits associated with probiotics, such as improved digestive health and immune function. There is a growing focus on preventive healthcare and overall wellness, leading consumers to seek products that support gut health. Probiotics are perceived as natural and effective supplements that can promote a healthy digestive system.

In a 2021 survey conducted by the International Food Information Council, findings indicated that 51% of Americans incorporate probiotics into their diets to promote gut health, 33% use them to bolster immune function, 38% integrate probiotics for overall health and wellness purposes, and 13% reported consuming probiotics to support emotional well-being. The higher use of probiotic supplements is parallelly expanding market growth.

Lack of Consumer Awareness

Many consumers are unaware of the health consequences associated with poor gut health, such as increased risks of heart attack, stroke, and dementia. MDVIP survey shows 3 in 5 Americans don't know an unhealthy gut can increase heart attack, stroke and dementia risk. Two-thirds of Americans are living with gut issues, unaware of the health consequences.

This lack of awareness can lead to lower demand for gut health products, including probiotic supplements. Without a clear understanding of how probiotics can contribute to digestive health, immune function, and overall well-being, consumers may not perceive these supplements as essential or beneficial. This limits market growth potential.

Segment Analysis

The global gut health probiotic supplements market is segmented based on strain, form, distribution channel, age group, application and region.

Increasing Prevalence of Specific Health Conditions

The global gut health probiotic supplements market is segmented based on application into general digestive health, specific health conditions and others. The specific health conditions segment accounted for the largest share of the global market. Irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) are some of the specific digestive health conditions that are commonly seen globally.

According to the International Foundation for Gastrointestinal Disorders, the worldwide estimation of IBS is reported to be 5-10% of the population. Similarly, in September 2023, results from a new study by Cedars-Sinai investigators revealed that irritable bowel syndrome is more prevalent than their previous estimation. The increasing prevalence of specific health conditions and the high prevalence of consumer willingness to take up natural curing measures drive segment growth.

Geographical Penetration

High Prevalence of Irritable Bowel Syndrome in North America

North America dominates the global gut health probiotic supplements market. North America, particularly United States and Canada, has a substantial population that is health-conscious and actively seeks preventive healthcare solutions. This strong cultural emphasis on health and wellness leads to a robust demand for products that support digestive health and overall well-being.

The high use of probiotic supplements in various aspects of application in North America is positively improving the market expansion in this region. According to the Food and Health Survey conducted by the International Food Information Council in April 2022, around 33% of respondents in United States try to include probiotics in their diets, with 60% aiming to do so daily.

North America's dominance in the global gut health probiotic supplements market is high due to the consumer interest in health and wellness and also advancements in product development. The region is a hub for research and innovation in healthcare and nutrition, fostering the development of advanced probiotic formulations and technologies along with the presence of leading global manufacturers.

Competitive Landscape

The major global players in the market include The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited, Unique Biotech Limited, Projoy Pvt Ltd, Nature's Bounty, Hyperbiotics, Advanced Vital Enzymes Private Ltd, Wren Laboratories Ltd and Nordic Naturals.

COVID-19 Impact Analysis

COVID-19 had a moderate impact on the global gut health probiotic supplements market. Initially, the market faced disruptions in raw material supply chains and manufacturing capabilities due to lockdowns and restrictions on movement. Some supplement manufacturers faced challenges in maintaining production levels and ensuring timely distribution due to logistical issues and workforce constraints.

The pandemic heightened awareness of the importance of immune health. Probiotics are known to support gut health, which in turn can influence immune function. This awareness may drive long-term demand for gut health supplements. With lockdowns and social distancing measures, there was a significant shift towards online shopping. This trend benefited e-commerce channels for supplement sales, allowing companies to reach consumers directly.

By Strain

  • Lactobacillus
  • Bifidobacterium
  • Streptococcus
  • Other

By Form

  • Tablet
  • Capsules
  • Liquid
  • Powder
  • Others

By Distribution Channel

  • Pharmacies/Drugstores
  • Specialty Stores
  • Online Retail
  • Other

By Age-Group

  • Children
  • Adults
  • Seniors

By Application

  • General Digestive Health
  • Specific Health Conditions
    • Irritable Bowel Syndrome (IBS)
    • Inflammatory Bowel Disease (IBD)
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In August 2023, Hyperbiotics introduced PRO-IBS Support. This innovative product features a dual-action synergistic blend of Lactiplantibacillus plantarum 299v and highly bioavailable Boswellia serrata extract. The formulation aims to effectively alleviate gut discomfort and dysfunction in individuals with IBS.
  • In August 2022, researchers at the University of Nottingham secured £1.8 million in funding for a three-year project to explore the potential benefits of cellulose-based food supplements for individuals suffering from Irritable Bowel Syndrome, focusing on colon fermentation.

Why Purchase the Report?

  • To visualize the global gut health probiotic supplements market segmentation based on strain, form, distribution channel, age group, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of gut health probiotic supplements market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global gut health probiotic supplements market report would provide approximately 78 tables, 74 figures and 235 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Strain
  • 3.2. Snippet by Form
  • 3.3. Snippet by Distribution Channel
  • 3.4. Snippet by Age Group
  • 3.5. Snippet by Application
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Health Consciousness Among Consumers
      • 4.1.1.2. Increasing Consumer Probiotics Consumption
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Consumer Awareness
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Strain

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
    • 7.1.2. Market Attractiveness Index, By Strain
  • 7.2. Lactobacillus
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Bifidobacterium
  • 7.4. Streptococcus
  • 7.5. Other

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Tablet
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Capsules
  • 8.4. Liquid
  • 8.5. Powder
  • 8.6. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Pharmacies/Drugstores
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Stores
  • 9.4. Online Retail
  • 9.5. Other

10. By Age Group

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 10.1.2. Market Attractiveness Index, By Age Group
  • 10.2. Children
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Adults
  • 10.4. Seniors

11. By Application

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.1.2. Market Attractiveness Index, By Application
  • 11.2. General Digestive Health
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Specific Health Conditions
    • 11.3.1. Irritable Bowel Syndrome (IBS)
    • 11.3.2. Inflammatory Bowel Disease (IBD)
  • 11.4. Other

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. The Good Bug
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Zeroharm Sciences Private Limited
  • 14.3. Menoveda Life Sciences Private Limited
  • 14.4. Unique Biotech Limited
  • 14.5. Projoy Pvt Ltd
  • 14.6. Nature's Bounty
  • 14.7. Hyperbiotics
  • 14.8. Advanced Vital Enzymes Private Ltd
  • 14.9. Wren Laboratories Ltd
  • 14.10. Nordic Naturals

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us